Price in deferred time of 15 minutes
|
Last quote
10/22/2024 -
15:08:14
|
Bid
10/22/2024 -
15:08:19
|
Bid Volume |
Ask
10/22/2024 -
15:08:19
|
Ask Volume |
|---|---|---|---|---|
|
98.72
-1.72
(
-1.71% )
|
98.71
|
341 |
98.72
|
1,106 |
Analysis date: 18.10.2024
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 13.09.2024.
Interest
Strong
Strong
Strong interest since 15.10.2024.
Earnings Rev Trend
-0.10
-0.10
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is negative since 20.08.2024 at a price of 100.40.
Evaluation
Undervalued
Undervalued
Based on its growth potential and our own criteria, at its current price the stock is moderately undervalued.
MT Tech Trend
Positive
Positive
The forty day Medium Term Technical Trend is positive since 16.08.2024. The confirmed Technical Reverse point (Tech Reverse - 1.75%) is 96.895.
4wk Rel Perf
0.98%
0.98%
The four week relative performance versus STOXX600 is .
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 15.03.2024.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 1.55%.
Mkt Cap in $bn
230.78
230.78
With a market capitalization >$8bn, NOVARTIS AG is considered a large-cap stock.
G/PE Ratio
1.02
1.02
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
13.62
13.62
The estimated PE is for the year 2026.
LT Growth
10.43%
10.43%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
19
19
Over the last seven weeks, an average of 19 analysts provided earnings per share estimates.
Dividend Yield
3.45%
3.45%
The twelve month estimated dividend yield represents 46.95% of earnings forecasts.
Beta
61
61
For 1% of index variation, the stock varies on average by 0.61%.
Correlation
0.39
0.39
Stock movements are strongly independent of index variations.
Value at Risk
12.13
12.13
The value at risk is estimated at CHF 12.13. The risk is therefore 12.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.01.2002
02.01.2002